MIDDLE EAST AND AFRICA CRISPR MARKET 2019-2028

Lifesciences | Diagnostic & Biotechnology

MIDDLE EAST AND AFRICA CRISPR MARKET 2019-2028

Market By Product, Application And End-user | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

A Triton Market Research report has determined that the CRISPR market in the Middle East and Africa will prosper at CAGR of 24.08% during the projected period 2019-2028.



We provide additional customization based on your specific requirements. Request For Customization

The countries scrutinized in the Middle East and Africa market are:

           Turkey

           United Arab Emirates

           South Africa

           Saudi Arabia

           Rest of Middle East & Africa

Turkey is part of the Cartagena Protocol on Biosafety, which is an agreement aiming to ensure the safe handling of living modified organisms. The Biosafety Law and its associated rules, which were implemented in September 2010, regulate biosafety applications in Turkey. Although the country typically does not allow the use of genetically modified organisms for food, the biosecurity council in Turkey approved the utility of three varieties of genetically modified soybeans. Such conformation to the increasing use of genetically modified organisms for the foods is expected to prosper the demand for the CRISPR (Clustered Regularly Interspaced Short Palindrome Repeats) market in Turkey, thereby growing the market growth.

It is reported that the Antiviral Gene Therapy Research Unit (AGTRU) at Wits University is currently undertaking research activities to develop a cure for hepatitis B, which is a virus that destroys the liver. The research team made use of CRISPR-Cas9 and TALENS gene-editing technique to combat the virus. The team has also been working on gene editing techniques against tuberculosis, another major disease in South Africa. These developments in the field of gene therapy are likely to drive the CRISPR market growth in South Africa.

Established in 1987, Integrated DNA Technologies Inc is a company that is involved in the development and manufacturing of custom oligonucleotides for the research & diagnostics life science market. It provides its products to different areas of academic research, and pharmaceutical & biotechnological development. It is specialized in the areas of gene splicing, DNA sequencing, transcription profiling, SNP detection, and DNA amplification. The company has business operations in the Middle East.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    MIDDLE EAST AND AFRICA CRISPR MARKET – SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. VALUE CHAIN OUTLOOK

2.4. SUPPLY CHAIN OUTLOOK

2.5. TIMELINE OF CRISPR MARKET

2.6. PARENT MARKET OUTLOOK

2.7. KEY INSIGHT

2.8. MARKET ATTRACTIVENESS INDEX

2.9. MARKET DRIVERS

2.9.1.   GROWING LIFESTYLE-ORIENTED DISEASES

2.9.2.   SURGING PREVALENCE OF GENETIC DISEASES

2.9.3.   INCREASING APPLICATION OF DRUGS

2.9.4.   RISING AGING POPULATION

2.9.5.   INCIDENCE OF GENETIC AILMENTS

2.10.  MARKET RESTRAINTS

2.10.1.  ETHICAL AND SOCIAL ISSUES ASSOCIATED WITH CRISPR TECHNOLOGY

2.10.2.  CHANGING REGULATORY ENVIRONMENT

2.11.  MARKET OPPORTUNITIES

2.11.1.  INCREASED DEMAND FOR CRISPR  

2.11.2.   ADVANCEMENTS IN THE APPLICATIONS OF GENE-BASED THERAPY

2.12.  MARKET CHALLENGES

2.12.1.  ALTERNATIVE TECHNOLOGIES

2.12.2. LACK OF AWARENESS REGARDING THE TECHNOLOGY

3.    CRISPR MARKET OUTLOOK - BY PRODUCT

3.1. PLASMIDS

3.2. VECTORS

3.3. PROTEINS

3.4. DESIGN TOOLS

3.5. GRNA

3.6. CONTROL KITS

3.7. LIBRARY

3.8. OTHER PRODUCTS

4.    CRISPR MARKET OUTLOOK - BY APPLICATION

4.1. GENOME EDITING/GENETIC ENGINEERING

4.2. GRNA DATABASE/GENE LIBRARY

4.3. CRISPR PLASMID

4.4. HUMAN STEM CELLS

4.5. CELL LINE ENGINEERING

5.    CRISPR MARKET OUTLOOK - BY END-USER

5.1. THERAPEUTICS & DRUG DISCOVERY

5.2. BIOLOGICAL RESEARCH

5.3. AGRICULTURAL BIOTECH

5.4. INDUSTRIAL BIOTECH

6.    CRISPR MARKET – MIDDLE EAST AND AFRICA

6.1. SAUDI ARABIA

6.2. TURKEY

6.3. UNITED ARAB EMIRATES

6.4. SOUTH AFRICA

6.5. REST OF MIDDLE EAST & AFRICA

7.    COMPANY PROFILE

7.1. ADDGENE

7.2. APPLIED STEMCELL

7.3. CARIBOU BIOSCIENCES INC

7.4. CELLECTIS

7.5. CRISPR THERAPEUTICS

7.6. DIACARTA

7.7. EDITAS MEDICINE

7.8. GENECOPOEIA INC

7.9. GENEDATA AG

7.10.  GENSCRIPT

7.11.  HORIZON DISCOVERY LTD

7.12.  INTEGRATED DNA TECHNOLOGIES INC

7.13.  INTELLIA THERAPEUTICS INC

7.14.    LONZA  

7.15.    NEW ENGLAND BIOLABS  

7.16.    ORIGENE TECHNOLOGIES INC

7.17.     PRECISION BIOSCIENCES

7.18.    SANGAMO THERAPEUTICS

7.19.  SIGMA-ALDRICH (MERCK KGAA)

7.20.    THERMO FISHER SCIENTIFIC INC

7.21.    TRANSPOSAGEN BIO (HERA BIOLABS)

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        MIDDLE EAST AND AFRICA CRISPR MARKET, 2019-2028 ($ MILLION)

TABLE 2        CHIEF CONCERNS RELATED TO GENETIC ENGINEERING

TABLE 3        MIDDLE EAST AND AFRICA CRISPR MARKET, BY PRODUCT, 2019-2028 ($ MILLION)

TABLE 4        TOOL NAMES AND THEIR PROVIDERS

TABLE 5        MIDDLE EAST AND AFRICA CRISPR MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 6        BARRIERS TO ENTRY IN THE AGRICULTURAL SEED MARKET

TABLE 7        AGRICULTURE BIOTECH TRAITS INDUSTRY

TABLE 8        MIDDLE EAST AND AFRICA CRISPR MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 9        MIDDLE EAST AND AFRICA CRISPR MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

List of Figures

FIGURE 1      MIDDLE EAST AND AFRICA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 2      VALUE CHAIN ANALYSIS

FIGURE 3      MIDDLE EAST AND AFRICA CRISPR MARKET, BY PLASMIDS, 2019-2028 ($ MILLION)

FIGURE 4      MIDDLE EAST AND AFRICA CRISPR MARKET, BY VECTORS, 2019-2028 ($ MILLION)

FIGURE 5      MIDDLE EAST AND AFRICA CRISPR MARKET, BY PROTEINS, 2019-2028 ($ MILLION)

FIGURE 6      MIDDLE EAST AND AFRICA CRISPR MARKET, BY DESIGN TOOLS, 2019-2028 ($ MILLION)

FIGURE 7      MIDDLE EAST AND AFRICA CRISPR MARKET, BY GRNA, 2019-2028 ($ MILLION)

FIGURE 8      MIDDLE EAST AND AFRICA CRISPR MARKET, BY CONTROL KITS, 2019-2028 ($ MILLION)

FIGURE 9      MIDDLE EAST AND AFRICA CRISPR MARKET, BY LIBRARY, 2019-2028 ($ MILLION)

FIGURE 10   MIDDLE EAST AND AFRICA CRISPR MARKET, BY OTHER PRODUCTS, 2019-2028 ($ MILLION)

FIGURE 11   MIDDLE EAST AND AFRICA CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 12   MIDDLE EAST AND AFRICA CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2019-2028 ($ MILLION)

FIGURE 13   MIDDLE EAST AND AFRICA CRISPR MARKET, BY CRISPR PLASMID, 2019-2028 ($ MILLION)

FIGURE 14   MIDDLE EAST AND AFRICA CRISPR MARKET, BY HUMAN STEM CELLS, 2019-2028 ($ MILLION)

FIGURE 15   MIDDLE EAST AND AFRICA CRISPR MARKET, BY CELL LINE ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 16   MIDDLE EAST AND AFRICA CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2019-2028 ($ MILLION)

FIGURE 17   MIDDLE EAST AND AFRICA CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2019-2028 ($ MILLION)

FIGURE 18   MIDDLE EAST AND AFRICA CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2019-2028 ($ MILLION)

FIGURE 19   MIDDLE EAST AND AFRICA CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2019-2028 ($ MILLION)

FIGURE 20   MIDDLE EAST AND AFRICA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 21   SAUDI ARABIA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 22   TURKEY CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 23   UNITED ARAB EMIRATES CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 24   SOUTH AFRICA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 25   REST OF MIDDLE EAST & AFRICA CRISPR MARKET, 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;